Montana SB317 prohibits health insurers from requiring prior authorization for psychiatric drugs that are in shortage or discontinued.
Montana SB317 amends the state's insurance laws to prohibit health insurers from performing prior authorization on psychiatric drugs that are in shortage or discontinued. This means that insurers cannot require additional approval before covering these medications. The bill also mandates that any adverse determination for a prescription drug made during prior authorization must be made by a physician specializing in the condition for which the drug was prescribed. This change aims to ensure that patients have timely access to necessary psychiatric medications.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.